Tumors of the prostate gland, seminal vesicles, penis, and scrotum:
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Washington, DC
American Registry of Pathology
2011
|
| Schriftenreihe: | AFIP atlas of tumor pathology
Fourth series ; 14 |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVII, 675 S. zahlr. Ill., graph. Darst. |
| ISBN: | 1933477148 9781933477145 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV039121988 | ||
| 003 | DE-604 | ||
| 005 | 20120716 | ||
| 007 | t | ||
| 008 | 110706s2011 ad|| |||| 00||| eng d | ||
| 020 | |a 1933477148 |9 1-933477-14-8 | ||
| 020 | |a 9781933477145 |9 978-1-933477-14-5 | ||
| 035 | |a (OCoLC)743205253 | ||
| 035 | |a (DE-599)BVBBV039121988 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-20 |a DE-19 |a DE-355 | ||
| 084 | |a XH 1702 |0 (DE-625)152872:12908 |2 rvk | ||
| 100 | 1 | |a Epstein, Jonathan I. |e Verfasser |0 (DE-588)142107530 |4 aut | |
| 245 | 1 | 0 | |a Tumors of the prostate gland, seminal vesicles, penis, and scrotum |c by Jonathan I. Epstein ; Antonio L. Cubilla ; Peter A. Humphrey |
| 264 | 1 | |a Washington, DC |b American Registry of Pathology |c 2011 | |
| 300 | |a XVII, 675 S. |b zahlr. Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a AFIP atlas of tumor pathology : Fourth series |v 14 | |
| 700 | 1 | |a Cubilla, Antonio L. |e Verfasser |4 aut | |
| 700 | 1 | |a Humphrey, Peter A. |e Verfasser |4 aut | |
| 830 | 0 | |a AFIP atlas of tumor pathology |v Fourth series ; 14 |w (DE-604)BV019661402 |9 14 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024140535&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024140535 | ||
Datensatz im Suchindex
| _version_ | 1804147953245356032 |
|---|---|
| adam_text | Titel: Tumors of the prostate gland, seminal vesicles, penis, and scrotum
Autor: Epstein, Jonathan I
Jahr: 2011
1. The Normal Prostate Gland....................................................................................................................................................................................1
Anatomy........................................................................................................................................................................................................................................1
Anatomic Models......................................................................................................................................................................................................2
Capsule ................................................................................................................................................................................................................................4
Blood Supply......................................................................................................................................................................................................................6
Lymphatic Drainage..............................................................................................................................................................................................7
Nerves..........................................................................................................................................................................................................................................7
Embryology and Developmental Anatomy..............................................................................................................................9
Histology........................................................................................................................................................................................................................................10
Immunohistochemistry..........................................................................................................................................................................................16
Ultrastructure..........................................................................................................................................................................................................................17
Prostate Function..............................................................................................................................................................................................................18
2. Benign Prostatic Hyperplasia................................................................................................................................................................................23
Prevalence....................................................................................................................................................................................................................................23
Clinical Features................................................................................................................................................................................................................24
Gross Findings......................................................................................................................................................................................................................25
Microscopic Findings..................................................................................................................................................................................................28
Immunohistochemical Findings..............................................................................................................................................................41
Molecular Genetic Findings............................................................................................................................................................................42
Differential Diagnosis................................................................................................................................................................................................42
Clinical Behavior and Treatment............................................................................................................................................................44
3. Prostatic Intraepithelial Neoplasia..............................................................................................................................................................49
Histology........................................................................................................................................................................................................................................49
Relationship of PIN to Carcinoma........................................................................................................................................................50
Differential Diagnosis................................................................................................................................................................................................60
Immunohistochemistry..........................................................................................................................................................................................68
Low-Grade PIN on Biopsy: Risk of Cancer on Rebiopsy......................................................................................68
High-Grade PIN on Biopsy: Incidence and Risk of Cancer on Rebiopsy....................................68
High-Grade PIN on TURP....................................................................................................................................................................................70
Intraductal Carcinoma of the Prostate............................................................................................................................................70
4. Acinar (Usual) Adenocarcinoma of the Prostate....................................................................................................................77
Epidemiology..........................................................................................................................................................................................................................77
Clinical Incidence......................................................................................................................................................................................................77
Mortality..................................................................................................................................................................................................................................79
Prevalence at Autopsy........................................................................................................................................................................................79
Clinical Risk Factors..............................................................................................................................................................................................80
ix
Tumors of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum
Prevention............................................................................................................................................................................................................................82
Clinical Features................................................................................................................................................................................................................82
Clinical Manifestations....................................................................................................................................................................................82
Digital Rectal Examination........................................................................................................................................................................83
Serum Prostate-Specific Antigen..........................................................................................................................................................83
Clinical Staging....................................................................................................................................................................................................................84
Pathologic Findings......................................................................................................................................................................................................87
Gross Findings................................................................................................................................................................................................................87
Location....................................................................................................................................................................................................................................88
Multifocality......................................................................................................................................................................................................................93
Microscopic Findings............................................................................................................................................................................................93
The Gleason Grading System........................................................................................................................................................................136
Gleason Patterns..........................................................................................................................................................................................................137
Grading Variants of Prostate Carcinoma................................................................................................................................154
Reporting Secondary Patterns of Lower Grade when Present to a
Limited Extent....................................................................................................................................................................................................158
Reporting Secondary Patterns of Higher Grade when Present to a Limited Extent 158
Tertiary Gleason Patterns..............................................................................................................................................................................158
Percent of Pattern 4 or 5..................................................................................................................................................................................159
Needle Biopsy with Different Cores Showing Different Grades........................................................159
Radical Prostatectomy Specimens with Different Nodules Showing Different
Grades..............................................................................................................................................................................................................................160
Prognosis of Patients with Various Gleason Patterns..........................................................................................160
Correlation of Grade with Serum PSA Levels..................................................................................................................160
Correlation of Grade between Biopsy and Radical Prostatectomy Specimen..............160
Change of Grade Over Time......................................................................................................................................................................161
Interobserver Reproducibility..................................................................................................................................................................161
Treatment......................................................................................................................................................................................................................................161
Active Surveillance ................................................................................................................................................................................................162
Surgery........................................................................................................................................................................................................................................162
Radiation Therapy....................................................................................................................................................................................................163
Hormone Therapy....................................................................................................................................................................................................165
Chemotherapy................................................................................................................................................................................................................165
Pathologic Staging, Spread, Metastases, and Prognosis........................................................................................166
pT2: Carcinoma Confined within the Prostate Gland......................................................................................166
PT2+..............................................................................................................................................................................................................................................166
pT3 ..............................................................................................................................................................................................................................................167
pT4: Invasion of Rectum or Gross Invasion of Urinary Bladder Neck......................................178
Perineural Invasion..................................................................................................................................................................................................179
x
Contents
Vascular Invasion........................................................................................................................................................................................................183
Primary Tumor Size................................................................................................................................................................................................184
pN: Lymph Node Metastasis....................................................................................................................................................................185
Distant Metastasis......................................................................................................................................................................................................189
Distant Nonbony Prostatic Carcinoma Metastasis................................................................................................190
Effects of Treatment on Malignant Prostate Tissue......................................................................................................195
Hormonal Therapy..................................................................................................................................................................................................195
Radiation Therapy....................................................................................................................................................................................................199
Cryotherapy........................................................................................................................................................................................................................204
Phytotherapy....................................................................................................................................................................................................................204
Chemotherapy................................................................................................................................................................................................................206
Special Studies........................................................................................................................................................................................................................206
Histochemistry..............................................................................................................................................................................................................206
Immunohistochemistry....................................................................................................................................................................................206
Treated Prostatic Adenocarcinoma..................................................................................................................................................208
Prostatic Carcinoma Versus Granulomatous Prostatitis..................................................................................209
High-Grade Prostatic Carcinoma Versus High-Grade Urothelial Carcinoma................209
Prostatic Adenocarcinoma Versus Secondary Adenocarcinoma........................................................209
Poorly Differentiated Prostatic Adenocarcinoma Versus Prostatic Small Cell
Carcinoma................................................................................................................................................................................................................212
Poorly Differentiated Prostatic Adenocarcinoma Versus Lymphoma and
Leukemia....................................................................................................................................................................................................................212
Metastatic Prostatic Adenocarcinoma........................................................................................................................................212
Immunohistochemistry for Predictive Markers for Targeted Therapy....................................213
Molecular Genetics..................................................................................................................................................................................................213
5. Variants of Prostatic Adenocarcinoma..................................................................................................................................................239
Prostatic Duct Adenocarcinoma................................................................................................................................................................239
Mucinous (Colloid) and Signet Ring Cell Adenocarcinoma..........................................................................249
Carcinomas with Squamous Differentiation..........................................................................................................................252
Tumors with Neuroendocrine Differentiation....................................................................................................................253
Sarcomatoid Carcinoma........................................................................................................................................................................................262
Pleomorphic Giant Cell Adenocarcinoma................................................................................................................................263
Miscellaneous Tumors..............................................................................................................................................................................................265
6. Basal Cell Tumors and Tumor-Like Conditions......................................................................................................................269
Basal Cell Hyperplasia..............................................................................................................................................................................................269
Basal Cell Carcinoma..................................................................................................................................................................................................279
7. Urothelial Tumors and Tumor-Like Lesions..................................................................................................................................289
Primary Urothelial Lesions................................................................................................................................................................................289
Urothelial Metaplasia..........................................................................................................................................................................................289
xi
Tumors of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum
Primary Urothelial Carcinoma..............................................................................................................................................................291
Secondary Urothelial Lesions........................................................................................................................................................................291
In Situ (Intraductal) Spread of Carcinoma..........................................................................................................................291
Invasive Urothelial Carcinoma............................................................................................................................................................292
Grading and Staging of Urothelial Carcinoma of the Prostate..................................................................297
8. Miscelaneous Epithelial Tumors of the Prostate....................................................................................................................299
Benign Epithelial Tumors....................................................................................................................................................................................299
Cystadenoma....................................................................................................................................................................................................................299
Oncocytoma......................................................................................................................................................................................................................301
Malignant Epithelial Tumors..........................................................................................................................................................................301
Clear Cell Carcinoma of the Utricle/Prostate..................................................................................................................301
9. Mesenchymal Tumors of the Prostate....................................................................................................................................................305
Benign Mesenchymal Tumors......................................................................................................................................................................305
Leiomyoma..........................................................................................................................................................................................................................305
Miscellaneous Benign Mesenchymal Tumors................................................................................................................305
Malignant Mesenchymal Tumors............................................................................................................................................................307
Leiomyosarcoma..........................................................................................................................................................................................................307
Rhabdomyosarcoma..............................................................................................................................................................................................309
Miscellaneous Malignant Mesenchymal Tumors......................................................................................................314
Mesenchymal Tumors of Uncertain Malignant Potential..................................................................................314
Solitary Fibrous Tumor......................................................................................................................................................................................314
Inflammatory Myofibroblasts Tumor............................................................................................................318
Secondary Involvement by Mesenchymal Tumors......................................................................................................321
Gastrointestinal Stromal Tumor..........................................................................................................................................................321
Stromal Tumors Arising from Specialized Prostatic Stroma............................................................................323
Stromal Tumors of Uncertain Malignant Potential..............................................................................................323
Stromal Sarcoma..........................................................................................................................................................................................................329
10. Hematolymphoid Tumors and Tumor-Like Lesions..........................................................................................................335
Lymphoma..................................................................................................................................................................................................................................335
Leukemia........................................................................................................................................................................................................................................340
Plasma Cell Myeloma................................................................................................................................................................................................342
Extramedullar Hematopoiesis....................................................................................................................................................................343
Signet Ring Lymphocytes....................................................................................................................................................................................343
11. Miscellaneous Tumors....................................................................................................................................................................................................347
Extragonadal Germ Cell Tumors..............................................................................................................................................................347
Ganglioneuroma................................................................................................................................................................................................................347
Lymphangiolipomatosis........................................................................................................................................................................................347
Malignant Rhabdoid Tumor............................................................................................................................................................................347
Malignant Mixed Tumor of Salivary Gland Type............................................................................................................347
xii
Contents
Malignant Perivascular Epithelioid Cell Tumor................................................................................................................348
Malignant Melanoma................................................................................................................................................................................................348
Ectomesenchymoma..................................................................................................................................................................................................348
Malignant Mesenchymoma..............................................................................................................................................................................349
Paraganglioma......................................................................................................................................................................................................................349
Primitive Neuroectodermal Tumor........................................................................................................................................................350
Wilms Tumor..........................................................................................................................................................................................................................351
Rare Secondary Tumors..........................................................................................................................................................................................351
12. Tumor-Like Lesions of the Prostate............................................................................................................................................................357
Adenosis..........................................................................................................................................................................................................................................357
Atrophy............................................................................................................................................................................................................................................367
Basal Cell Hyperplasia..............................................................................................................................................................................................374
Clear Cell Cribriform Hyperplasia (Cribriform Hyperplasia)........................................................................374
Malakoplakia............................................................................................................................................................................................................................374
Mesonephric Hyperplasia....................................................................................................................................................................................374
Nephrogenic Adenoma............................................................................................................................................................................................377
Nonspecific Granulomatous Prostatitis..........................................................................................................................................380
Prostatic Urethral Polyps......................................................................................................................................................................................382
Sclerosing Adenosis......................................................................................................................................................................................................383
Squamous Metaplasia adjacent to Infarcts................................................................................................................................386
Verumontanum Mucosal Gland Hyperplasia........................................................................................................................387
Xanthoma....................................................................................................................................................................................................................................388
13. Normal Nonprostatic Tissue in Prostate Specimens..........................................................................................................393
Seminal Vesicles..................................................................................................................................................................................................................393
Colonic Mucosa..................................................................................................................................................................................................................393
Cowper Glands....................................................................................................................................................................................................................393
Paraganglia..................................................................................................................................................................................................................................402
Signet Ring Lymphocytes....................................................................................................................................................................................402
14. Tumors of the Penis............................................................................................................................................................................................................405
Anatomy and Histology........................................................................................................................................................................................405
Distal (Anterior) Penis.......................................................................................................405
Proximal Penis (Peneal Body, or Shaft)....................................................................................................................................410
Posterior (Root) Penis..........................................................................................................................................................................................411
Penile Urethra..................................................................................................................................................................................................................412
Lymphatic Vessels and Inguinal Lymph Nodes..........................................................................................................413
Vascular Supply and Innervation......................................................................................................................................................413
Classification of Penile Tumors..................................................................................................................................................................414
Histologic Classification of Penile Tumors..........................................................................................................................415
Benign Epithelial Tumors....................................................................................................................................................................................416
xiii
Tumors of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum
Condyloma Acuminatum..............................................................................................................................................................................416
Penile Horn and Micaceous Balanitis..........................................................................................................................................418
Adnexal Tumors............................................................................................................................................................................................................419
Epithelial Abnormalities and Precancerous Lesions..................................................................................................419
Squamous Hyperplasia......................................................................................................................................................................................419
Bowenoid Papulosis................................................................................................................................................................................................422
Flat Acetowhite Penile Lesions......................................................................................................................................................423
Penile Intraepithelial Neoplasia..........................................................................................................................................................423
Differentiated Penile Intraepithelial Neoplasia............................................................................................................425
Penile Intraepithelial Neoplasia with Warty and/or Basaloid Features..................................427
Mixed or Coexisting Penile Intraepithelial Neoplasia......................................................................................436
Squamous Cell Carcinoma: General Features......................................................................................................................436
Epidemiology....................................................................................................................................................................................................................436
Pathologic Features..................................................................................................................................................................................................444
Site of Origin....................................................................................................................................................................................................................445
Secondary Tumors Associated with Penile Cancer..................................................................................................445
Molecular Pathology............................................................................................................................................................................................447
Patterns of Growth..................................................................................................................................................................................................449
Histologic Subtypes of Squamous Cell Carcinoma......................................................................................................451
Histologic Classification..................................................................................................................................................................................451
Squamous Cell Carcinoma, Usual Type..................................................................................................................................452
Basaloid Carcinoma................................................................................................................................................................................................460
Verrucous Carcinoma..........................................................................................................................................................................................467
Warty (Condylomatous) Carcinoma............................................................................................................................................475
Papillary Carcinoma, Not Otherwise Specified............................................................................................................478
Sarcomatoid Carcinoma..................................................................................................................................................................................486
Pseudoglandular Carcinoma....................................................................................................................................................................495
Pseudohyperplastic Carcinoma............................................................................................................................................................497
Carcinoma Cuniculatum................................................................................................................................................................................500
Adenosquamous Carcinoma....................................................................................................................................................................502
Mixed Carcinomas....................................................................................................................................................................................................506
Unclassified Carcinomas................................................................................................................................................................................511
Squamous Cell Carcinoma: Prognostic Factors..................................................................................................................511
Histologic Grade..........................................................................................................................................................................................................516
Perineural Invasion..................................................................................................................................................................................................520
Vascular Invasion........................................................................................................................................................................................................522
Depth of Invasion or Tumor Thickness..................................................................................................................................522
Anatomic Levels of Invasion....................................................................................................................................................................524
Anatomic Location..................................................................................................................................................................................................525
xiv
Contents
Patterns of Growth..................................................................................................................................................................................................526
Front of Invasion........................................................................................................................................................................................................526
Size of Primary Tumor........................................................................................................................................................................................526
Histologic Subtypes................................................................................................................................................................................................527
Koilocytosis..........................................................................................................................................................................................................................527
Positive Resection Margins..........................................................................................................................................................................527
Urethral Invasion......................................................................................................................................................................................................529
Risk Group Stratification Systems....................................................................................................................................................530
Algorithms and Nomograms....................................................................................................................................................................531
Limitations in the Pathologic Evaluation of Prognostic Factors......................................................533
The Prognostic Index............................................................................................................................................................................................533
Routes of Cancer Spread........................................................................................................................................................................................536
Local Spread........................................................................................................................................................................................................................536
Regional Spread............................................................................................................................................................................................................53 7
Recurrent Carcinomas........................................................................................................................................................................................538
Disseminated Cancer............................................................................................................................................................................................540
Squamous Cell Carcinoma: Diagnostic Procedures, Staging, and Treatment......................541
Noninvasive and Minimally Invasive Diagnostic Procedures..............................................................541
Staging of Penile Carcinoma....................................................................................................................................................................543
Treatment of Penile Carcinoma..........................................................................................................................................................544
Standard Surgical Treatment....................................................................................................................................................................544
Penile-Preserving Therapy............................................................................................................................................................................545
Radiotherapy....................................................................................................................................................................................................................546
Laser Ablation..................................................................................................................................................................................................................546
Chemotherapy................................................................................................................................................................................................................546
Multimodality Therapy....................................................................................................................................................................................546
Other Epithelial Tumors........................................................................................................................................................................................546
Giant Condyloma (Tumor of Buschke-Löwenstein)............................................................................................546
Clear Cell Carcinoma..........................................................................................................................................................................................549
Paget Disease......................................................................................................................................................................................................................551
Malignant Melanoma..........................................................................................................................................................................................552
Miscellaneous Other Rare Epithelial Tumors..................................................................................................................554
Nonepithelial Tumors................................................................................................................................................................................................554
Mesenchymal Tumors........................................................................................................................................................................................554
Benign Mesenchymal Tumors................................................................................................................................................................554
Malignant Mesenchymal Tumors......................................................................................................................................................556
Malignant Lymphoma and Related Lesions......................................................................................................................560
Tumors Metastatic to Penis................................................................................................................................................................................560
Tumor-Like Lesions........................................................................................................................................................................................................561
xv
Tumors of the Prostate Gland, Seminal Vesicles, Penis, and Scrotum
Cysts..............................................................................................................................................................................................................................................562
Verruciform Xanthoma....................................................................................................................................................................................566
Peyronie Disease..........................................................................................................................................................................................................568
Papillomatosis of Glans Corona..........................................................................................................................................................569
Lipogranuloma..............................................................................................................................................................................................................570
Lichen Sclerosus..........................................................................................................................................................................................................571
Melanosis (Lentiginosis)..................................................................................................................................................................................573
Os Penis....................................................................................................................................................................................................................................574
Frozen Section Evaluation of Penile Cancer..........................................................................................................................575
Circumcision Specimen....................................................................................................................................................................................575
Parital Penectomy Specimen....................................................................................................................................................................575
Total Penectomy Specimen........................................................................................................................................................................575
Lymph Nodes..................................................................................................................................................................................................................575
Guidelines for Handling the Resected Specimen............................................................................................................575
Foreskin....................................................................................................................................................................................................................................575
Foreskin, Coronal Sulcus, and Glans............................................................................................................................................576
Urethral Margin............................................................................................................................................................................................................576
Shaft Margin......................................................................................................................................................................................................................576
Glans..............................................................................................................................................................................................................................................576
Reporting of Resected Specimens of Penile Carcinoma........................................................................................577
15. Tumors of the Scrotum..................................................................................................................................................................................................613
Anatomy and Histology........................................................................................................................................................................................613
Anatomic Layers..........................................................................................................................................................................................................613
Blood Supply......................................................................................................................................................................................................................614
Lymphatic Vessels......................................................................................................................................................................................................614
Nerve Supply....................................................................................................................................................................................................................614
Benign Epithelial Tumors....................................................................................................................................................................................614
Condyloma Acuminatum..............................................................................................................................................................................614
Adnexal Tumors............................................................................................................................................................................................................615
Malignant Epithelial Tumors..........................................................................................................................................................................616
Squamous Cell Carcinoma..........................................................................................................................................................................616
Extramammary Paget Disease................................................................................................................................................................627
Basal Cell Carcinoma............................................................................................................................................................................................628
Malignant Melanoma..........................................................................................................................................................................................631
Merkel Cell Carcinoma and Other Neuroendocrine Tumors................................................................631
Miscellaneous Skin Adnexal Tumors............................................................................................................................................633
Benign Mesenchymal Tumors......................................................................................................................................................................633
Angiokeratoma..............................................................................................................................................................................................................633
Hemangioma....................................................................................................................................................................................................................634
xvi
Contents
Lymphangioma............................................................................................................................................................................................................635
Leiomyoma..........................................................................................................................................................................................................................635
Angiomyxoid Tumors..........................................................................................................................................................................................636
Angiomyofibroblastoma..................................................................................................................................................................................639
Cellular Angiofibroma........................................................................................................................................................................................639
Other Benign Mesenchymal Tumors..........................................................................................................................................640
Malignant Mesenchymal Tumors............................................................................................................................................................640
Leiomyosarcoma..........................................................................................................................................................................................................640
Liposarcoma........................................................................................................................................................................................................................641
Malignant Fibrous Histiocytoma........................................................................................................................................................641
Malignant Lymphoma..............................................................................................................................................................................................641
Secondary Tumors..........................................................................................................................................................................................................641
Tumor-Like Lesions........................................................................................................................................................................................................641
Verruciform Xanthoma....................................................................................................................................................................................641
Porokeratosis of Mibelli....................................................................................................................................................................................645
Idiopathic Scrotal Calcinosis and Epidermoid Cysts....................................................................................646
Sclerosing Lipogranuloma ( Paraffinoma )......................................................................................................................650
Post-Traumatic Spindle Cell Nodule............................................................................................................................................651
Scrotal Hamartoma including Accessory Scrotum..................................................................................................652
Fibrous Hamartoma of Infancy............................................................................................................................................................652
Smooth Muscle Hamartoma of Dartos......................................................................................................................................652
Isolated Exophytic Elastoma....................................................................................................................................................................654
Scrotal Fat Necrosis..................................................................................................................................................................................................654
Acute Idiopathic Scrotal Edema..........................................................................................................................................................654
Polymorphic Reticulosis of Genital Skin................................................................................................................................655
Index ..............................................................................................................................................................................................................................................665
xvii
|
| any_adam_object | 1 |
| author | Epstein, Jonathan I. Cubilla, Antonio L. Humphrey, Peter A. |
| author_GND | (DE-588)142107530 |
| author_facet | Epstein, Jonathan I. Cubilla, Antonio L. Humphrey, Peter A. |
| author_role | aut aut aut |
| author_sort | Epstein, Jonathan I. |
| author_variant | j i e ji jie a l c al alc p a h pa pah |
| building | Verbundindex |
| bvnumber | BV039121988 |
| classification_rvk | XH 1702 |
| ctrlnum | (OCoLC)743205253 (DE-599)BVBBV039121988 |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01466nam a2200337 cb4500</leader><controlfield tag="001">BV039121988</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20120716 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110706s2011 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1933477148</subfield><subfield code="9">1-933477-14-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781933477145</subfield><subfield code="9">978-1-933477-14-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)743205253</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV039121988</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-20</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1702</subfield><subfield code="0">(DE-625)152872:12908</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Epstein, Jonathan I.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)142107530</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Tumors of the prostate gland, seminal vesicles, penis, and scrotum</subfield><subfield code="c">by Jonathan I. Epstein ; Antonio L. Cubilla ; Peter A. Humphrey</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, DC</subfield><subfield code="b">American Registry of Pathology</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 675 S.</subfield><subfield code="b">zahlr. Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">AFIP atlas of tumor pathology : Fourth series</subfield><subfield code="v">14</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cubilla, Antonio L.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Humphrey, Peter A.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">AFIP atlas of tumor pathology</subfield><subfield code="v">Fourth series ; 14</subfield><subfield code="w">(DE-604)BV019661402</subfield><subfield code="9">14</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024140535&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024140535</subfield></datafield></record></collection> |
| id | DE-604.BV039121988 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T23:59:25Z |
| institution | BVB |
| isbn | 1933477148 9781933477145 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024140535 |
| oclc_num | 743205253 |
| open_access_boolean | |
| owner | DE-20 DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| owner_facet | DE-20 DE-19 DE-BY-UBM DE-355 DE-BY-UBR |
| physical | XVII, 675 S. zahlr. Ill., graph. Darst. |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | American Registry of Pathology |
| record_format | marc |
| series | AFIP atlas of tumor pathology |
| series2 | AFIP atlas of tumor pathology : Fourth series |
| spelling | Epstein, Jonathan I. Verfasser (DE-588)142107530 aut Tumors of the prostate gland, seminal vesicles, penis, and scrotum by Jonathan I. Epstein ; Antonio L. Cubilla ; Peter A. Humphrey Washington, DC American Registry of Pathology 2011 XVII, 675 S. zahlr. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier AFIP atlas of tumor pathology : Fourth series 14 Cubilla, Antonio L. Verfasser aut Humphrey, Peter A. Verfasser aut AFIP atlas of tumor pathology Fourth series ; 14 (DE-604)BV019661402 14 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024140535&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Epstein, Jonathan I. Cubilla, Antonio L. Humphrey, Peter A. Tumors of the prostate gland, seminal vesicles, penis, and scrotum AFIP atlas of tumor pathology |
| title | Tumors of the prostate gland, seminal vesicles, penis, and scrotum |
| title_auth | Tumors of the prostate gland, seminal vesicles, penis, and scrotum |
| title_exact_search | Tumors of the prostate gland, seminal vesicles, penis, and scrotum |
| title_full | Tumors of the prostate gland, seminal vesicles, penis, and scrotum by Jonathan I. Epstein ; Antonio L. Cubilla ; Peter A. Humphrey |
| title_fullStr | Tumors of the prostate gland, seminal vesicles, penis, and scrotum by Jonathan I. Epstein ; Antonio L. Cubilla ; Peter A. Humphrey |
| title_full_unstemmed | Tumors of the prostate gland, seminal vesicles, penis, and scrotum by Jonathan I. Epstein ; Antonio L. Cubilla ; Peter A. Humphrey |
| title_short | Tumors of the prostate gland, seminal vesicles, penis, and scrotum |
| title_sort | tumors of the prostate gland seminal vesicles penis and scrotum |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024140535&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV019661402 |
| work_keys_str_mv | AT epsteinjonathani tumorsoftheprostateglandseminalvesiclespenisandscrotum AT cubillaantoniol tumorsoftheprostateglandseminalvesiclespenisandscrotum AT humphreypetera tumorsoftheprostateglandseminalvesiclespenisandscrotum |